Access and Commercial Strategy (ACS)

If you’re a medical manufacturer, how are you demonstrating value to drive your growth?

Covance’s Access and Commercial Strategy Group (ASC) helps medical manufacturers like you optimize the access potential of your medical products.

Covance delivers access consulting, such as reimbursement/landscape assessments and market strategy/launch planning; market research to measure attitudes of key audiences; and policy analyses to understand and shape payment policies for complex new products or regimens.

Then, we can help with execution with program design/launch implementation; sales training; data tools and customer education.

Covance sees a broader market. We can help you understand it and satisfy it from inception to execution.

  • Policy Research and Analysis
  • Policies are always changing. Covance keeps you current with consulting services, policy analyses, strategic support, and insight on policy developments and trends to ensure appropriate payment and positioning, for new or existing products, and with payer and provider audiences.

    Covance’s extensive policy knowledge and multidisciplinary approach involving experts within the Covance Market Access team leads to creative solutions.

  • Market Access Modeling
  • What’s the revenue potential of your product? How will product adoption affect provider finances? That knowledge could make a significant difference in your product development and market strategy.

    With its in-depth knowledge of payment policy and product economics, Covance develops sophisticated models – internal, patient assistance exposure and customer facing -- that can help you understand potential constraints as your product develops. That information supplies insight on customer messaging and selling tools.

  • Market Research
  • Your drug candidate will help patients, but will also change clinical practice and treatment pathways. As the drug is developed, you’ll need to understand the incentives, perspectives, and decision-making processes of payers, providers, and other relevant stakeholders.

    Covance plans, executes, and analyzes qualitative and semi-quantitative market research that informs your thinking about expectations, concerns, and needs of key audiences. Securing that data is vital to help develop potential messaging and sales approaches that will appeal to your decision makers. Services include:

    • • Qualitative interviews
    • • Competitive benchmarking
    • • Advisory boards
    • • On-line and other quantitative surveys
    • • Multiple stakeholders: payers, providers, patients,
         and specialty pharmacies
    • • Stakeholder panels
  • Market Access Strategy
  • Your drug candidate is unique. The strategy to bring it to market should be, too.

    With decades of experience supporting product launches, Covance draws on its payment policy, coding, customer support, health economics, outcomes and patient assistance know-how to assess your product in context of the access environment, and develop the go-to-market approach that positions your product in its most positive light. Services include:

    • • Strategy development
    • • Program research (including benchmarking)
    • • Program design
    • • Patient access programs
    • • Reimbursement programs
    • • Patient assistance programs
    • • Field team strategy and deployment
    • • Drug compendia strategy development
  • Customer, Sales and Market support
  • Inspired, strategic planning requires results-oriented execution. With three decades of developing and managing access programs, Covance creates and applies the right mix of tactical tools to support your reimbursement, access and customer support requirements. Services include:

    • • Customer support strategy
    • • Reimbursement education
    • • In-house sales training
    • • Billing and other guides
    • • Sales tools and training
    • • Customer educational programs
    • • Field team operations
    • • Website content

On Demand:

Unique Market Access Considerations for Small Biopharmas
by John McDermott, John Carlsen and Tracy Mayne, PhD

Optimizing Your Drug Development Begins Here
What brought you here today?

*First Name

*Last Name






*Company Email

General Questions/Comments

I would like to be contacted.

*Required Fields

Home | Animal Welfare | Privacy Statement | Terms of Use | Cookie Statement | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2014 Covance Inc. All rights reserved.